Helping adults with intellectual and developmental disabilities quit smoking
Adapting and Testing a Smoking Cessation Intervention in Adults with Intellectual and Developmental Disabilities
['FUNDING_CAREER'] · UNIVERSITY OF KENTUCKY · NIH-11061831
This project aims to create and test a personalized program to help adults with intellectual and developmental disabilities stop smoking.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KENTUCKY (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-11061831 on ClinicalTrials.gov |
What this research studies
Smoking is a major health risk, especially for adults with intellectual and developmental disabilities (IDDs) who often face more health problems like diabetes and asthma. People with IDDs also find it harder to get into and stay in smoking cessation programs due to various challenges. This project will work closely with the IDD community to understand these difficulties. Using this feedback, researchers will adapt an existing, proven smoking cessation program to better fit the needs of adults with IDDs and then test how well it works.
Who could benefit from this research
Good fit: Ideal candidates are adults aged 21 and older who have intellectual and developmental disabilities and currently smoke cigarettes.
Not a fit: Patients who do not smoke or do not have intellectual and developmental disabilities would not directly benefit from this specific smoking cessation program.
Why it matters
Potential benefit: If successful, this work could provide a much-needed effective smoking cessation program tailored specifically for adults with intellectual and developmental disabilities, improving their overall health and reducing smoking-related diseases.
How similar studies have performed: The core smoking cessation approach is evidence-based, but its adaptation and testing specifically for adults with intellectual and developmental disabilities represent a novel application.
Where this research is happening
LEXINGTON, UNITED STATES
- UNIVERSITY OF KENTUCKY — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: REGNIER, SEAN — UNIVERSITY OF KENTUCKY
- Study coordinator: REGNIER, SEAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.